WASHINGTON, Dec 6- The U.S. Supreme Court agreed on Friday to rule on the divisive issue of what kinds of software are eligible for patent protection in a case being closely watched by the technology industry. The court took no action on another case raising the same issue involving a patent dispute between WildTangent Inc and Ultramercial Inc..» Read More
*Myriad Genetics shares up more than 10 percent after ruling. WASHINGTON, June 13- In a first of its kind ruling on human genes, a unanimous U.S. Supreme Court on Thursday decided that synthetically produced genetic material can be patented but naturally occurring DNA extracted from the human body cannot.
WASHINGTON, June 13- The U.S. Supreme Court on Thursday ruled partially for Myriad Genetics Inc on the closely watched issue of whether human genes can be patented, deciding synthetically produced genetic material can be patented but naturally occurring DNA cannot. Myriad's shares jumped more than 8 percent to $36.83 after the ruling was issued.
WASHINGTON, June 13- The U.S. Supreme Court on Thursday issued a mixed ruling in a case concerning patents held by Myriad Genetics Inc over the closely watched issue of whether human genes can be patented.
Dennis Berman of The Wall Street Journal and Gene Munster of Piper Jaffray discuss how the ruling against Apple will likely affect the company and its stock price.
CNBC's Jon Fortt reports the details on the battle between the two tech titans over a patent infringement suit.
The "Squawk on the Street" news team reports on today's top business headlines, including this morning's ADP employment numbers; the effectiveness of Japanese Prime Minister Abe's "third arrow" economic plan, and a patent infringement setback for Apple.
"I don't think it's that big," said Jonathan Geller, Boy Genius Report, discussing Samsung winning the latest round in its long-running patent battle with Apple.
The Supreme Court will hear arguments in a case that calls into question whether DNA can be claimed as intellectual property, and remain off limits without the permission of the patent holder.
India's top court has dealt a serious blow to Western pharmaceutical firms who are increasingly focusing on India to drive sales.
Cloud-based service for remote device access announced a victory a in patent litigation case. CNBC's Josh Lipton reports the stock jumped on the news.
AstraZeneca settled a patent dispute with generic drug maker Watson Laboratories over its cholesterol drug Crestor, reports CNBC's Bertha Coombs.
A judge threw out part of the $1 billion verdict for Apple in its patent battle with Samsung and ordered a new trial.
A U.S. appeals court on Thursday rejected Apple request to revive its bid for a sales ban on Samsung's Galaxy Nexus smartphone.
Google unit Motorola Mobility has asked a trade panel to drop two key patents from an infringement complaint that it filed against Microsoft.
John Lechleiter, Chairman, President & CEO of Eli Lilly, discusses why he expects profits to rise this year despite a wave of patent expirations.
Nokia shareholders are unhappy with the details of the patent dispute settlement with Research In Motion, and Hovnanian is up about 370 percent year-to-date, with the FMHR traders.
A federal jury on Wednesday found that Marvell Technology Group infringed two patents held by Carnegie Mellon University, and ordered the chipmaker to pay $1.17 billion in damages.
Struggling Finnish mobile phone maker Nokia has settled its patent dispute with BlackBerry maker Research in Motion in return for payments, as it tries to exploit its trove of technology patents to boost its finances.
Korea's Samsung Electronics on Tuesday said it would drop law suits aimed at banning the sale of Apple products in Europe.
Mad Money host Jim Cramer explains why he thinks VirnetX makes for an intriguing speculative play, saying there is nothing wrong with a little reasoned gambling in your portfolio on this risky trade.